Cystic fibrosis, a genetic disorder, affects lungs and other organs. It causes thick mucus buildup. Researchers have identified over 2,000 gene muta ...
AUSTIN, Texas and TOKYO, Dec. 1, 2025 /PRNewswire/ --According to DataM Intelligence, the Cystic Fibrosis (CF) Therapeutics Market Size accelerated to USD 10.60 billion in 2024, up from USD 9.22 ...
The MarketWatch News Department was not involved in the creation of this content. Cystic Fibrosis Therapeutics Market Set to Reach USD 35.09 Billion by 2033 as Precision CFTR Modulator Therapies ...
AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.
So far, the company's commercialized drugs have delivered billions of dollars in revenue. For example, in the latest quarter, Vertex's revenue soared 11% to more than $3 billion -- that's with net ...
A H3N2 virus - dubbed 'super flu' - is sweeping hospitals in England - and people with one health condition may be more at ...
News-Medical.Net on MSN
Flu wave’s hidden cost on people with cystic fibrosis
People with cystic fibrosis (CF) are uniquely vulnerable to the flu wave currently ripping through the UK, a clinical ...
Clinical Trials Arena on MSN
4DMT’s gene therapy hopeful for cystic fibrosis shows promise in Phase I trial
If approved, gene therapies could fill gaps in patient care left by CFTR modulators, notes GD Healthcare analyst, Vinie Varkey.
Two mutated alleles of the cystic fibrosis transmembrane conductance regulator (CFTR) gene result in the autosomal recessive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback